ArticleOncoTargets and therapy2026

LOXL 2 Promotes the Epithelial-Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.